Israeli researchers use a modified plant virus to grow «improved» cannabis»
Israeli researchers used advanced technology to grow a cannabis variety an improved strain that contains higher levels of THC and CBG, the main active components of cannabis, thereby opening up new possibilities for the medical and recreational industries.
As part of research conducted at the Robert H. Smith Faculty of Agriculture, Food, and Environment at the Hebrew University of Jerusalem, researchers have succeeded in creating and cultivating a cannabis plant containing nearly 17 % of THC and 25 % of CBG.
The laboratory-developed strain also had a 20 to 30 % higher concentration of terpenes, which is responsible for the smell and taste of cannabis, but also for the modulation of the effects of cannabis.
According to a press release issued by the university, the goal of the study was to develop a mechanism that would allow researchers to intervene in the biochemical pathways of the cannabis plant and modify the levels of active compounds it produces.
Researchers have finally succeeded in increasing or decreasing the levels of specific substances by manipulating a plant virus and redirecting it. Instead of harming the plant, the researchers created a version of the virus capable of affecting the genes in the cannabis plant that influence the production of its active compounds.
«This represents an innovative use of these tools, which were developed using synthetic biology techniques,» said declared Professor Alexander Vainstein, who led the project.
"Manipulating a cannabis plant and altering the levels of its active compounds or their proportions has never been done before," the university noted, opening up new possibilities for the medical industry.
«The results of this study will be invaluable both to the industry, in order to increase the yield of active compounds, and to medical research, in order to cultivate and develop new strains for users of medical marijuana«, said Mr. Vainstein, adding that further experiments will be conducted with the modified plant and that the information will be made available to the cannabis industry in the coming months.
-
Business3 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France4 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec2 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Business4 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in Morocco4 weeks ago
Morocco: Three Cannabis-Based Medications Approved for the Treatment of Epilepsy
-
Business4 weeks ago
Aurora Cannabis Doubles Its Production Capacity in Germany
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died


You must be logged in to post a comment Login